Trials / Conditions / Prodromal Schizophrenia

Prodromal Schizophrenia

18 registered clinical trials studyying Prodromal Schizophrenia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	EPI-MINN: Targeting Cognition and Motivation - National NCT05877716	University of Minnesota	N/A
Completed	Feasibility Trial of a Lifestyle Intervention for CHR-P NCT05532683	University of California, Los Angeles	N/A
Recruiting	Effects of NAC on Symptoms of CHR Patients NCT05142735	Centre for Addiction and Mental Health	N/A
Unknown	Accelerated TMS in Psychosis NCT05567848	Beth Israel Deaconess Medical Center	Phase 1 / Phase 2
Terminated	REtinal and VIsual Cortical Response in Early PSYchosis NCT05167396	Centre Psychothérapique de Nancy	N/A
Recruiting	Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer NCT05052853	China Medical University Hospital	Phase 2
Recruiting	Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk NCT05131035	Northwell Health	N/A
Active Not Recruiting	Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial NCT04338152	University of California, Los Angeles	N/A
Completed	Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk NCT06190483	King's College London	N/A
Enrolling By Invitation	Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis NCT03970005	Ohio State University	—
Unknown	Early Detection and Intervention for Women At-risk of Psychosis NCT03751865	The University of Hong Kong	N/A
Completed	Neurofeedback Training for High Risk Psychosis NCT03447548	Hartford Hospital	N/A
Terminated	"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Pati NCT03149107	University Hospital, Bonn	Phase 3
Completed	Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis NCT01619319	University of Calgary	N/A
Completed	Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study NCT01269710	University of North Carolina, Chapel Hill	—
Completed	Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms NCT00169988	Northwell Health	N/A
Terminated	Aripiprazole Treatment of the Prodrome NCT00169949	Northwell Health	N/A
Completed	Psychosis: Early Detection, Intervention and Prevention NCT01597141	MaineHealth	N/A